Severe Hemorrhage Associated With Oral Anticoagulants-Reference-Cited by-同舟云学术

Severe Hemorrhage Associated With Oral Anticoagulants

Published:2020-05-01 Issue: Volume: Page:
ISSN:1866-0452
Container-title:Deutsches Ärzteblatt international
language:
Short-container-title:

Author:

Lindhoff-Last Edelgard,Herrmann Eva,Lindau Simone,Konstantinides Stavros,Grottke Oliver,Nowak-Goettl Ulrike,Lucks Jessica,Zydek Barbara,von Heymann Christian,Birschmann Ingvild,Sümnig Ariane,Beyer-Westendorf Jan,Schellong Sebastian,Meybohm Patrick,Greinacher Andreas

Publisher

Deutscher Arzte-Verlag GmbH

Subject

General Medicine

Reference20 articles.

1. Patel MR, Mahaffey KW, Garg J, et al.: Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 2011; 365: 883–91

2. Connolly SJ, Ezekowitz MD, Yusuf S, et al.: Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009; 361: 1139–51

3. Granger CB, Alexander JH, McMurray JJ, et al.: Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2011; 365: 981–92

4. Einstein investigators, Bauersachs R, Berkowitz SD, et al.: Oral rivaroxaban for symptomatic venous thromboembolism. N Engl J Med 2010; 363: 2499–510

5. Giugliano RP, Ruff CT, Braunwald E, et al.: Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2013; 369: 2093–104

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bleeding Outcomes of Direct Oral Anticoagulants and Vitamin K Antagonists for Acute Venous Thromboembolism: A Cross-Sectional Study;Cureus;2024-05-19

2. Engineering and evaluation of FXa bypassing agents that restore hemostasis following Apixaban associated bleeding;Nature Communications;2024-05-09

3. Clinical Course and Management of Patients with Emergency Surgery Treated with Direct Oral Anticoagulants or Vitamin K Antagonists—Results of the German Prospective RADOA-Registry;Journal of Clinical Medicine;2024-01-03

4. Anticoagulant-associated fatalities;Rechtsmedizin;2023-02-10

5. Pharmacokinetics of Phenprocoumon in Emergency Situations–Results of the Prospective Observational RADOA-Registry (Reversal Agent Use in Patients Treated with Direct Oral Anticoagulants or Vitamin K Antagonists Registry);Pharmaceuticals;2022-11-19